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Abstract:  This study evaluates the Speech Intelligibility Index (SII) as a tool to 
describe hearing loss and predict when hearing aids would be appropriate for 
pediatric oncology patients who have received or are currently receiving 
cisplatin. The efficacy of the SII is compared to the Brock grade which is 
commonly used for patients with ototoxic hearing loss secondary to cisplatin 
treatment. The SII is a discrete measure that precisely reflects the patient’s 
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 LITERATURE REVIEW  
Cisplatin ototoxicity in pediatric oncology patients has been well documented and currently 
several scales exist to classify the high-frequency hearing loss associated with this treatment.1-10  
Although there are many ways to classify ototoxicity, it is most commonly defined by one of the 
three following classification systems—Brock Grade1, American Speech Language Hearing 
Association (ASHA) hearing loss classification2, and the National Cancer Institute Common 
Terminology Criteria for Adverse Events version 3.0 (NCI CTCAEv3)11.   Most recently, the 
Chang grading scale was introduced as a modification of the Brock grade to classify 
ototoxicity.12  Each of these four scales serves a somewhat different purpose. 
 The Brock grade was specifically designed to characterize platinum-induced high-
frequency hearing loss.1  This system is based on severity of high-frequency hearing loss for the 
better hearing ear, with grades from 0 to 4 with grade 4 representing the most severe hearing loss 
(see Table 1).  Recently, Chang and Chinosornvatana developed a modified Brock grade 
designed to more accurately reflect the patient’s need for a frequency modulation (FM) system 
and/or hearing aids.12  The Chang grading scale is more sensitive to functional deficits than the 
Brock grade due to inclusion of hearing thresholds less than 40 dB HL and thresholds at the 
interoctaves 6000 and 3000 Hz (see Table 1).  It is proposed that the Chang grading scale is more 
useful in predicting the need for hearing aids and/or FM systems than the NCI CTCAEv3.0 
scale; however, further research is warranted.12 
 The NCI CTCAEv.3 scale was specifically designed for patients involved in an 
ototoxicity monitoring program and to identify the presence of hearing loss that could affect a 
person’s ability to communicate.11 This four-level system combines threshold information, 





standard toxicity scale used in large-scale clinical pediatric trials and is often the basis for 
subsequent dose reductions within a study.11   
The ASHA scale was designed for early detection of threshold shifts to potentially 
minimize or prevent hearing loss.2  This scale classifies ototoxicity into three groups relative to 
the baseline audiogram (see Table 1).  Thresholds at 250, 500, 1000, 2000, 3000, 4000, 6000, 
and 8000 Hz, and if possible, ultra-high frequencies (9000, 10,000, 11,000, 12,000, 14,000, 
16,000, 18,000 and 20,000 Hz) are considered.  Any decrease or loss of response must be 
confirmed by repeat testing within 24 hours of the test session.2 The utility of the ASHA scale in 
monitoring patients and adjusting ototoxic therapy such as platinum agents in cancer patients has 
not been clearly established. (personal communication, Robert J. Hayashi) 
Significant differences among these classification systems make comparisons difficult.3,9  
The Brock grade is based on a medical model of grades to represent severity of loss of the better 
ear.  The Chang grading scale, also based on a medical model of grades, prefers that each ear be 
graded individually.  In the event that only one grade is to be given, then the grade would be 
based on the worse ear (personal communication, Kay W. Chang).  The grading scales of Brock 
and Chang are familiar to oncologists due to their design, which is tailored for platinum 
ototoxicity, with increasing grades tracking the characteristic declines in hearing in this patient 
population.  In contrast, the ASHA and NCI CTCAEv.3.0 scales can be used with unilateral or 
bilateral changes, typically classifying loss based on the worse ear.  Both ASHA and NCI 
CTCAEv.3.0 are designed to alert clinicians to the onset of mild hearing loss due to ototoxicity.  
The Brock grade is based on thresholds > 40 dB HL; whereas, NCI CTCAEv.3.0 and ASHA are 





An important issue for clinicians is determining when the severity of the loss warrants 
intervention.  None of the three most commonly used and researched scales addresses the 
functional hearing status of the patient, which would help guide intervention strategies such as 
hearing aids, FM systems and classroom accommodations.  In contrast, the Chang grading scale 
attempts to account for functional hearing status.   However, there are currently no reports 
further validating the scale and assessing its application within clinical settings. 
A tool that accurately reflects functional loss and can assist clinicians in conveying its 
impact to patients and families is the speech intelligibility index (SII).  The SII was created in 
1997 as a major revision of the 1986 Articulation Index (AI).13  The AI is a physical measure 
developed by communication engineers to quantify the relationship between the portion of the 
average speech spectrum that remains audible in the presence of filtering, noise distortion and 
low speech level.13  It was originally developed to assist engineers in the design of telephone 
communications systems but has been more recently used as an audiologic counseling tool14, a 
means for selecting various amplification systems15-16 and the prediction of speech 
intelligibility16-18.  Like the AI, the SII is also a physical measure highly correlated with the 
intelligibility of speech under a variety of adverse listening conditions such as noise, filtering and 
reverberation.  Critical to the study of ototoxic hearing loss, the SII has more emphasis on the 
high frequencies (6000 and 8000 Hz.) than the AI.19  The SII is interpreted as the total number of 
speech cues to reach the listener.  If all speech cues reach the listener the SII is 1.0; whereas, if 
no speech cues reach the listener the SII is 0.0.20  According to the ANSI 1997 standard, a good 
communication system has a SII >.75 and a poor communication system has a SII <.45.20 
The SII is computed as a product of the frequency band importance function (Ii, a 





intelligibility) and the band audibility function (Ai, a number between 0 and 1 specifying the 
effective proportion of the speech dynamic range within the band that contributes to speech 
intelligibility under less than optimal conditions) summed over the total number of frequency 
bands in the computations.20 
   ⁿ   
  SII = ∑   Ii Ai 
   i=1 
 
There are four methods to calculate the SII: 1) Critical Frequency Band (21 bands), 2) One-Third 
Octave Frequency Band (18 bands), 3) Equally Contributing Critical Band (17 bands), 4) Octave 
Frequency Band (6 bands).  The basic steps of the four computations are essentially the same. 
The formulas differ only in the number and the size of the frequency bands.  Since more 
frequency bands increase accuracy, the Critical Frequency Band method is the most precise of 
the four listed.20 
Research involving the SII and the pediatric population is sparse.  The SII has been used 
with normal hearing adults to predict speech intelligibility under realistic conditions21 as well as 
to predict speech reception thresholds for sentences in fluctuating noise.22  The SII has also been 
used to study hearing impairment and hearing aids as well as automated calculations with 
manufacturers probe microphone equipment in children and adults.23  To the author’s 
knowledge, no published accounts use the SII to classify ototoxic hearing loss.   
This study aims to evaluate the Speech Intelligibility Index (SII)20 as a tool to describe 
hearing loss and predict when hearing aids would be appropriate for pediatric oncology patients 
who have received or are currently receiving cisplatin.  In particular, the following questions 
have been examined:  1) Is there a specific value of the SII that would serve as a criterion for 









The study was approved by the Washington University School of Medicine Human Research 
Protection Office. Retrospective chart analysis was performed on pediatric oncology patients 
treated between August 1990 and April 2007 at St. Louis Children’s Hospital. This review 
generated a list of 160 patients treated with the chemotherapeutic drug cisplatin.  Eligibility 
criteria required that patients were treated with the chemotherapy agent cisplatin, have an 
audiogram obtained at least six months after the last cisplatin administration and all conductive 
hearing losses were excluded.  To distinguish a platinum-induced, high-frequency sensorineural 
hearing loss from a conductive loss, the air-bone gap was evaluated.  If results indicated an air-
bone gap ≥15 dB above 1 kHz, the ear was excluded from entry.  Ears for which there was 
decreased hearing with no bone conduction measures were excluded if tympanometry indicated a 
static admittance of ≤ .2 mmho.  Patients were also excluded if the pure tone thresholds were not 
obtained bilaterally at the following test frequencies: 500, 1000, 2000, 4000 and 8000 Hz.  
Seventy-eight patients met eligibility criteria; however, patient number fifty-one was excluded 
from analysis due to extreme asymmetric hearing loss (i.e., profound loss in the left ear and 
normal hearing from 500 to 4000 Hz with a severe loss above 6000 Hz in the right ear).  
Variables recorded included the following: age, gender, diagnosis, first and last day of cisplatin 








Audiologic assessments were performed at St. Louis Children’s Hospital by licensed 
audiologists.  The age, physical status and cooperation of the patient determined whether visual 
reinforcement audiometry (VRA), conditioned play audiometry (CPA) or conventional 
audiometry was used.  Due to the nature of pediatric audiologic assessment, not all frequencies 
were tested for each patient.  If the audiometric thresholds tested did not include 6000 Hz, it was 
interpolated based on the average of 4000 and 8000 Hz rounded up to the nearest five dB. 
Both Brock grade and SII values were recorded for both ears.  (see appendix D)  SII 
values were calculated by the Verifit Audioscan (Audioscan) using 1/3 octave bands, and 
expressed as a number ranging between 1.0 (full reception) and 0.0 (no reception).  Audioscan 
uses linear interpolation for bands between entered audiogram points.  For those frequencies 
external to the entered audiogram: the SPL threshold at the lowest entered frequency is used for 
each 1/3 octave band between this point and 200 Hz (inclusive); the SPL threshold at the highest 
entered frequency is used for each 1/3 octave band between this frequency and 8000 Hz 
(inclusive).  (personal communication, Chris Stokes Rees)  
The need for hearing aids was based on judgments from three pediatric audiologists with 
an average of 15 years of experience fitting/managing hearing aids in a practice of approximately 
500 active patients.  Based on patient age and audiometric data the three audiologists 
independently evaluated the need for hearing aids.  The audiologists judged the extent to which 
hearing aids would be recommended based on the following ranking: 1) Definitely would not 
recommend hearing aids, 2) Most likely would not recommend hearing aids, 3) Could go either 
way, 4) Most likely would recommend hearing aids, 5) Definitely would recommend hearing 





they would like to have at their disposal when making a decision on whether or not to fit a child 
with hearing aids.  Additionally, they were also asked to comment on the reasoning behind 
choosing to fit a child with hearing aids and any additional intervention methods (FM system, 
speech and language evaluation, preferential seating, etc.) they may have recommended.   
 
STATISTICAL METHODS 
Descriptive analysis with mean, standard deviation and proportion was used to describe patient 
characteristics, SII and Brock grade data.  Kappa value and intra-class correlations (ICC) were 
calculated to test agreement among the three audiologists.  Sensitivity and specificity of SII with 
a < 0.8 cut-off value were calculated for SII compared to Brock grade.  SAS version 9.1 software 
was used for statistical analyses. 
 
RESULTS 
Patient characteristics are listed in Table 2 for age, gender, diagnosis and cumulative cisplatin 
dosage.   The SII (minimum, maximum, average and standard deviation) is compared to the 
Brock grade for both ears in Table 3.  Data for individual ears are displayed in Figure 1, with a 
scatter plot comparison between Brock grade and the SII.   
Figure 2 displays the mean ranking of each audiogram from the panel of three 
audiologists as a function of the SII value of the worse ear.  Figure 3 displays the mean ranking 
of each audiogram from the panel of three audiologists as a function of the SII value of the better 
ear.  In general, the audiologists were in agreement as to which patients were in need of 
amplification and those that did not.  Furthermore, the SII values correlated with the 
audiologists’ consensus for the need of amplification with patients with a value < 0.8 receiving 





.95.  Kappa statistics could not be calculated for agreement involving audiologist three because 
audiologist three never used category three (could go either way) in their hearing aid rankings.  
Because Kappa statistics could not be performed for agreement involving audiologist three, 
intra-class correlations (ICC) were calculated for the remaining agreement statistics.  ICC for 
audiologists one and three was .96 with a 95% confidence interval (.93-.97).  ICC for 
audiologists two and three was .97 with a 95% confidence interval (.94-.98).  Thus, agreement 
among the three audiologists was consistently high. 
Sensitivity, specificity and efficiency are shown in Table 4 for SII and Brock grade for 
both the better and worse ear using several criteria.   A cutoff criterion for hearing aids or 
intervention has not been specified for the Brock grade.  To optimize the sensitivity and 
specificity measures for the Brock grade two logical cutoff scores were evaluated: Brock grade 2 
as passing and Brock grade 2 as failing.  As reflected in the data, the SII was associated with a 
high sensitivity, specificity and efficiency for both ears. 
 
DISCUSSION 
This report supports the use of the SII to describe the functional hearing status of pediatric 
patients with ototoxic hearing loss secondary to chemotherapeutic treatment with cisplatin.  In 
contrast to the Brock grading system, the SII gives a more precise measurement of the clinical 
impact of the hearing loss for the patient.  Of particular interest are the large range of SII scores 
for Brock grades 2 and 3.  Patients with Brock grade 2 had SII scores ranging from .59 to .86.  
Patients with Brock grade 3 had scores ranging from .37 to .59.  In fact, some patients with 
Brock grades of 2 or 3 had SII scores that varied by more than 25%, indicating that the SII, by its 





wide range of scores suggests that the SII is better than the Brock grade at representing the 
nuances of functional hearing status and would be more sensitive to subtle progression of hearing 
loss.  
Sensitivity, specificity and efficiency were calculated for a variety of conditions for both 
SII and Brock grade (see Table 4) in an attempt to optimize criteria for each scale. For the 
patients studied, the SII with a <.8 criterion for the worse ear provided the best match to the 
hearing aid recommendations of the three audiologists, with 100% sensitivity, specificity and 
efficiency. The Brock grade for the better ear with a criterion of grade 2 as the indicator of the 
need for hearing aids also provided excellent agreement with the audiologists with 95% 
sensitivity, specificity and efficiency.  
 The Chang grading scale was developed to improve upon the Brock grade by adding 
subcategories for Brock grades 1 and 2 and modifying grade 3.  Grade 4 remains unchanged.  
(see Table 1)   Although the Chang grading scale begins to address the issue of correlating 
audiologic measures with the need for FM systems and/or hearing aids, it does not account for 
individual variation to the same extent as the SII.  The SII is a more precise measure than the 
Chang grading scale or Brock grade because the audiogram is converted into a dynamic index, 
which accounts for individual variation in functional hearing status.  
According to the 1997 SII ANSI standard, a good communication system for an adult has 
an SII in excess of .75.  Published data for a good communication system for children are 
lacking.  Data from the current study with cisplatin treated pediatric cancer patients support an 






It is known that children with hearing loss have greater difficulty hearing in noise23-25 and 
that schools typically have poor acoustic environments.  Children spend the majority of their 
time in classrooms, which often exhibit excessive levels of background noise that can negatively 
affect their speech perception.26  This is especially true for children younger than fifteen years of 
age, who tend to be in the noisiest classrooms.26-28  For children to take advantage of both 
structured lessons and incidental learning they need to have a communication system that is 
appropriate for their age, language ability and acoustical environment.  In recognition of these 
factors, the three audiologists often recommended the use of FM systems to improve the signal to 
noise ratio within the school setting.  (see appendices—A to C—for the comments of the 
audiologists) 
In addition to environmental obstacles, children are at a disadvantage relative to adults 
because they have not fully developed speech and language skills and therefore, they are not as 
capable of filling in inaudible information to complete the message appropriately.  Thus, a 
slightly more conservative SII for children seems justified.  The judgments of the three 
experienced audiologists suggested that a SII of <.80 is appropriate for children compared to the 
<.75 SII value commonly used for adults.  Further validation with other audiologists at other 
centers serving pediatric oncology patients is needed. 
The three audiologists all commented that recent advances in hearing aid technology with 
frequency compression and frequency transposition enable audiologists to aid children with high 
frequency losses that previously would not have benefited from a hearing aid.  Two examples are 
depicted in Figures 4 and 5.  Figure 4 is an example of a patient who received an audiologist 
ranking of three (could go either way regarding recommendation of hearing aids). Additional 





and language evaluation.  Figure 5 is an example of a patient who received an audiologist 
ranking of four (most likely would recommend hearing aids).  Additional recommendations by 
the audiologists for this patient included use of a FM system, speech and language evaluation 
and preferential seating.  Examining the rankings and comments of the audiologists suggests that 
they frequently gave a ranking of three when the hearing loss was present at 4000 Hz and a 
ranking of four when the loss began to impact 3000 Hz.  
An advantage for the SII relative to the Brock grade and Chang grading scale is that 
future advances in technology enabling the fitting of even milder hearing loss can be 
accommodated by merely changing one number, the cut-off score within the index, rather than 
creating a new scale.   
 The audiologists participating in the study stated that case histories would have been 
beneficial in making hearing aid decisions.   This is particularly true for oncology patients.  The 
medical team, which has worked closely with the patient and family, are in the best position to 
know whether the timing is appropriate to begin audiologic intervention.  In clinical practice the 
audiologists would have access to thorough case histories and parent reports.  Clinical decisions 
are most often based primarily on the audiogram but other factors such as parent commitment, 
realistic expectations, the motivation/desire of the child, academic performance, speech and 
language evaluations, perceived difficulties and in the case of this special population the medical 
prognosis are considered.  Having a reduced SII does not guarantee a successful hearing aid 
fitting.  All intervention options should be discussed with the family and children who are old 
enough should be included in the counseling sessions. 
Based on the comments from the audiologists, even with a ranking of one (definitely 





seating, investigated the need for speech and language evaluation, and considered the use of a 
FM system.  For audiograms receiving a ranking of 5, the audiologists would definitely have 
recommended preferential seating, a FM system and a speech and language evaluation.  
Preferential seating tends to be a universal recommendation regardless of hearing loss or 
audiologist ranking.  In the study, recommendations were made depending solely on age of the 
patient and threshold information. The audiologists often made the comment that in clinical 
practice recommendations would be based on patient concerns or problems observed by the 
audiologists or other professionals working with the child and family. Again, these observations 
support the need for a team approach when working with these patients.  
Limitations to the current study were restricted age range due to audiologic criteria, the 
small number of audiologists used to determine the validation measure, and not formally asking 
about intervention strategies other than hearing aids.  Including a variety of audiologists from 
several medical centers and surveying all of the common intervention strategies (e.g. hearing 
aids, FM, speech/language evaluation/therapy, preferential seating, auditory training) are needed 
to validate the criterion and to learn more about intervention options.  Obtaining complete testing 
for all required audiometric frequencies is a challenge, particularly for children under three years 
of age.  Therefore, future research is needed to determine the best ways of interpolating and 
extrapolating from incomplete data to accommodate inclusion of these younger patients.  
In summary, the SII, which can be easily generated from conventional audiograms, 
results in a discrete measure that precisely reflects the patient’s functional hearing status and is 
highly correlated with the recommendation for hearing aids.   The SII has the potential to have 
great utility in the clinical arena as an easy to interpret measurement to guide clinicians and 





children with hearing loss who are not receiving cisplatin.  Further investigation is needed to 






 Overview of the four scales available to track ototoxicity 
The Brock Grade The Chang Grading Scale 
0  < 40 dB HL at 250 to 8000 Hz 0 ≤ 20 dB HL at 1000, 2000 and 4000 Hz 
1a  ≥ 40 dB HL at any frequency 6000 to 12000 Hz 1  ≥ 40 dB HL at 8000 Hz 
1b > 20 dB HL and < 40 dB at 4000 Hz 
2a ≥ 40 dB HL at 4000 Hz and above 2  ≥ 40 dB HL at 4000 Hz and 
above 2b > 20 dB HL and < 40 dB at any frequency below 
4000 Hz 
3 ≥ 40 dB HL at 2000 Hz and 
above 
3 ≥ 40 dB HL at 2000 or 3000 Hz and above 
4 ≥ 40 dB HL at 1000 Hz and 
above 
4 ≥ 40 dB HL at 1000 Hz and above 
 
National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events 
Version 3.0 (CTCAEv3) 
 
Category  
Level 1 Threshold increase of 15 to 25 dB in relation to the initial audiologic exam for two 
or more sequential frequencies in at least one ear or a subjective change in the 
absence of a level one shift 
Level 2 Threshold increase of 25 to 90 dB in two sequential frequencies in at least one ear 
Level 3 Hearing loss sufficient to indicate therapeutic intervention, including hearing aids 
(i.e. threshold shift in the speech frequencies equal to or greater than 20 dB 
bilaterally or 30 dB unilaterally) 




American Speech Language Hearing Association (ASHA) Hearing Loss Classification 
 
Category  
A 20 dB decrease at any one test frequency 
B 10 dB decrease at any 2 adjacent frequencies 







Table 2:  
Patient Information 
Number of Patients 77 
Gender  
     Males 40 (52%) 
     Females 37 (48%) 
Age Range at Test Date (years) 2.68 to 19.42 
     Average Age at Test Date (years) 10.78 
Diagnosis:  
    Adrenal Cortical Carcinoma 2 
     Astrocytoma 1 
     Ependymoma 4 
     Germ Cell Tumor 9 
     Hepatoblastoma 3 
     Medulloblastoma 14 
     Neuroblastoma 13 
     Osteosarcoma 25 
     Pineoblastoma 1 
     PNET 4 
     Thymoma 1 
Cisplatin Cumulative Dose Average (mg/m2) 392.99 






Table 3:   





of Ears Avg. SII Min. SII Max SII 
Standard 
Deviation 
0 53 0.99 0.85 1 0.025 
1 49 0.94 0.86 1 0.042 
2 29 0.74 0.59 0.86 0.077 
3 23 0.48 0.37 0.59 0.058 



















1  Definitely would not recommend hearing aids 
2 Most likely would not recommend hearing aids 
3 Recommendation could go either way 
4 Most likely would recommend hearing aids 














1  Definitely would not recommend hearing aids 
2 Most likely would not recommend hearing aids 
3 Recommendation could go either way 
4 Most likely would recommend hearing aids 






Correlation of various test conditions for the SII and Brock grades with the recommendation of 
hearing aids by 3 experienced audiologists.  
 








86% 100% 96% 
 Brock Grade  
(Worse Ear) 
≥ Grade 3 criterion 
59% 100% 88% 
Brock Grade 
(Better Ear) 
≥ Grade 3 Criterion 
45% 100% 84% 
Brock Grade 
(Worse Ear) 
≥ Grade 2 Criterion 
100% 89% 92% 
Brock Grade  
(Better Ear) 
≥ Grade 2 Criterion 






Figure 4:  









Figure 5:  
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Preferential seating if issues arise or when school aged 
Sit in front of auditorium classes at college 
Speech and language evaluation if warranted 
FM system if concerns arise when school aged 
Counseling with family on potential of progression of hearing 
loss 
Only pursue amplification if patient is having issues and wishing 




Speech and language due to age 
Trial with frequency compression/transposition depending on 
motivation and school performance 
Recommendations would depend on family and child motivation 




Speech and language evaluation 
FM system 
Trial with frequency compression/transposition depending on 
motivation and school performance 
ENT consultation due to asymmetry between ears 




Speech and language evaluation 
FM system 
Frequency transposition/compression hearing aid 
 
Audiologist Ranking 
1  Definitely would not recommend hearing aids 
2 Most likely would not recommend hearing aids 
3 Recommendation could go either way 
4 Most likely would recommend hearing aids 













Hearing loss at 3000 Hz automatic hearing aid 
6 yrs or younger always got a speech and language 
evaluation 
First ID, ENT consult 




FM and preferential seating for any patient with any amount 
of hearing loss 
Retest hearing ASAP if change  
Done with treatment, annual testing 
Still on treatment, per protocol 
First ID, ENT consult 




Hearing loss at 2000 Hz, automatic hearing aid 
FM systems for all patients with a hearing loss 
No preferential seating for hearing loss at 8000 Hz only 
Loss at 4000-8000 Hz does not automatically qualify for a 
hearing aid based on audiogram alone 
Loss in the speech frequencies 500-4000 Hz, 
recommendation was hearing aid, FM system and 
preferential seating 
Any hearing loss should have an ENT evaluation 




















Instructions Provided to Audiologists 
 
Author met with each audiologist 
Recommendations for a hearing aid were based on a scale from 1-5: 
 
1: Definitely would not recommend 
 
2: Most likely would not recommend 
 
3: Could go either way 
 
4: Most likely would recommend 
 
5: Definitely would recommend 
 
Assume normal middle ear function and speech discrimination that is in 
accordance with pure tones.   
 
Provide comments to support your rating, particularly for ratings of 2, 3 or 4. Note 
any additional recommendations that you would consider.  Note any additional 





Please Circle One 
 
1   2   3   4            5 
 
Comments: □FM System        □Preferential seating      







































1 2 2 0.59 0.6 5 4 5 4.67 
2 3 3 0.5 0.54 5 5 5 5 
3 1 1 0.93 0.98 1 1 1 1 
5 1 1 0.89 0.92 1 3 1 1.67 
11 3 3 0.4 0.48 5 5 5 5 
15 1 1 0.93 0.98 1 1 1 1 
17 1 0 0.98 0.99 1 1 1 1 
18 1 1 0.92 0.92 1 1 1 1 
19 1 0 0.99 1 1 1 1 1 
20 3 2 0.45 0.86 4 5 5 4.67 
22 0 0 0.97 1 1 1 1 1 
26 1 0 0.97 0.99 1 1 1 1 
27 3 3 0.41 0.42 5 5 5 5 
28 0 0 1 1 1 1 1 1 
29 3 3 0.37 0.38 5 5 5 5 
34 0 0 1 1 1 1 1 1 
36 3 3 0.54 0.55 5 5 5 5 
37 1 1 1 1 1 1 1 1 
39 1 1 0.92 0.92 1 1 1 1 
40 2 2 0.64 0.66 5 5 5 5 
41 0 0 1 1 1 1 1 1 
43 1 1 0.92 0.92 1 2 1 1.33 
44 2 1 0.8 0.92 3 3 2 2.67 
46 0 0 1 1 1 1 1 1 
47 2 2 0.81 0.81 3 3 1 2.33 
48 3 3 0.48 0.5 5 5 5 5 
49 2 1 0.82 0.86 3 3 1 2.33 
52 3 2 0.51 0.63 5 5 5 5 
56 2 2 0.71 0.73 5 5 4 4.67 
62 1 1 1 1 1 1 1 1 
64 0 0 1 1 1 1 1 1 
65 2 2 0.81 0.82 3 3 1 2.33 
66 2 2 0.75 0.77 5 4 4 4.33 
72 0 0 1 1 1 1 1 1 
76 0 0 1 1 1 1 1 1 
77 3 3 0.47 0.59 5 5 5 5 
78 3 3 0.43 0.46 5 5 5 5 
79 0 0 0.99 1 1 1 1 1 
80 3 3 0.5 0.52 5 5 5 5 
82 2 0 0.83 1 2 1 1 1.33 
84 2 2 0.76 0.77 5 4 4 4.33 
87 0 0 1 1 1 1 1 1 
88 0 0 0.99 1 1 1 1 1 





93 2 2 0.67 0.69 5 4 4 4.33 
95 2 2 0.8 0.83 4 3 1 2.67 
97 1 1 0.97 0.98 1 1 1 1 
102 1 1 1 1 1 1 1 1 
106 1 1 0.98 0.99 1 1 1 1 
107 2 2 0.73 0.74 5 3 4 4 
108 1 0 0.95 1 1 1 1 1 
113 0 0 1 1 1 1 1 1 
116 1 1 0.96 0.96 1 1 1 1 
117 0 0 1 1 1 1 1 1 
118 3 3 0.47 0.48 5 5 5 5 
119 1 1 0.86 0.92 3 3 1 2.33 
121 1 1 0.91 0.94 1 1 1 1 
125 1 1 0.86 0.9 3 2 1 2 
126 0 0 1 1 1 1 1 1 
127 2 2 0.76 0.8 5 4 4 4.33 
129 0 0 1 1 1 1 1 1 
130 1 0 0.99 0.99 1 1 1 1 
131 0 0 1 1 1 1 1 1 
132 1 0 0.93 1 1 1 1 1 
134 1 0 0.99 1 1 1 1 1 
136 0 0 0.85 0.93 2 2 1 1.67 
137 1 1 0.92 0.97 1 1 1 1 
138 1 1 0.93 0.94 1 1 1 1 
140 3 2 0.56 0.61 5 5 5 5 
141 1 1 0.93 0.93 1 1 1 1 
142 1 1 0.91 0.93 1 1 1 1 
146 1 0 0.92 0.98 1 1 1 1 
147 0 0 1 1 1 1 1 1 
151 0 0 0.99 1 1 1 1 1 
152 0 0 0.98 1 1 1 1 1 
153 2 1 0.72 0.86 4 4 4 4 
154 0 0 0.97 0.99 1 1 1 1 
 
 
 
 
